180 related articles for article (PubMed ID: 30910956)
1. Risk variants disrupting enhancers of T
Gao P; Uzun Y; He B; Salamati SE; Coffey JKM; Tsalikian E; Tan K
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7581-7590. PubMed ID: 30910956
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
Kim SS; Hudgins AD; Yang J; Zhu Y; Tu Z; Rosenfeld MG; DiLorenzo TP; Suh Y
PLoS One; 2021; 16(9):e0257265. PubMed ID: 34529725
[TBL] [Abstract][Full Text] [Related]
3. Disease-Associated Single-Nucleotide Polymorphisms From Noncoding Regions in Juvenile Idiopathic Arthritis Are Located Within or Adjacent to Functional Genomic Elements of Human Neutrophils and CD4+ T Cells.
Jiang K; Zhu L; Buck MJ; Chen Y; Carrier B; Liu T; Jarvis JN
Arthritis Rheumatol; 2015 Jul; 67(7):1966-77. PubMed ID: 25833190
[TBL] [Abstract][Full Text] [Related]
4. 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk.
Liu N; Sadlon T; Wong YY; Pederson S; Breen J; Barry SC
Epigenetics Chromatin; 2022 Jun; 15(1):24. PubMed ID: 35773720
[TBL] [Abstract][Full Text] [Related]
5. Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases.
Woo HJ; Yu C; Reifman J
PLoS One; 2017; 12(1):e0169918. PubMed ID: 28081217
[TBL] [Abstract][Full Text] [Related]
6. Regulation of inflammation in diabetes: From genetics to epigenomics evidence.
Diedisheim M; Carcarino E; Vandiedonck C; Roussel R; Gautier JF; Venteclef N
Mol Metab; 2020 Nov; 41():101041. PubMed ID: 32603690
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of super enhancer SNPs for type 2 diabetes.
Sun W; Yao S; Tang J; Liu S; Chen J; Deng D; Zeng C
PLoS One; 2018; 13(1):e0192105. PubMed ID: 29385209
[TBL] [Abstract][Full Text] [Related]
8. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
Onengut-Gumuscu S; Chen WM; Burren O; Cooper NJ; Quinlan AR; Mychaleckyj JC; Farber E; Bonnie JK; Szpak M; Schofield E; Achuthan P; Guo H; Fortune MD; Stevens H; Walker NM; Ward LD; Kundaje A; Kellis M; Daly MJ; Barrett JC; Cooper JD; Deloukas P; ; Todd JA; Wallace C; Concannon P; Rich SS
Nat Genet; 2015 Apr; 47(4):381-6. PubMed ID: 25751624
[TBL] [Abstract][Full Text] [Related]
9. Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes.
Ge Y; Concannon P
Eur J Hum Genet; 2018 Jul; 26(7):1060-1064. PubMed ID: 29491471
[TBL] [Abstract][Full Text] [Related]
10. Predicting cell types and genetic variations contributing to disease by combining GWAS and epigenetic data.
Gerasimova A; Chavez L; Li B; Seumois G; Greenbaum J; Rao A; Vijayanand P; Peters B
PLoS One; 2013; 8(1):e54359. PubMed ID: 23382893
[TBL] [Abstract][Full Text] [Related]
11. Enrichment of Genetic Variants for Rheumatoid Arthritis within T-Cell and NK-Cell Enhancer Regions.
Freudenberg J; Gregersen P; Li W
Mol Med; 2015 Mar; 21(1):180-4. PubMed ID: 25794145
[TBL] [Abstract][Full Text] [Related]
12. High-throughput functional dissection of noncoding SNPs with biased allelic enhancer activity for insulin resistance-relevant phenotypes.
Duan YY; Chen XF; Zhu RJ; Jia YY; Huang XT; Zhang M; Yang N; Dong SS; Zeng M; Feng Z; Zhu DL; Wu H; Jiang F; Shi W; Hu WX; Ke X; Chen H; Liu Y; Jing RH; Guo Y; Li M; Yang TL
Am J Hum Genet; 2023 Aug; 110(8):1266-1288. PubMed ID: 37506691
[TBL] [Abstract][Full Text] [Related]
13. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics.
Chiou J; Geusz RJ; Okino ML; Han JY; Miller M; Melton R; Beebe E; Benaglio P; Huang S; Korgaonkar K; Heller S; Kleger A; Preissl S; Gorkin DU; Sander M; Gaulton KJ
Nature; 2021 Jun; 594(7863):398-402. PubMed ID: 34012112
[TBL] [Abstract][Full Text] [Related]
14. Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility.
Ram R; Mehta M; Nguyen QT; Larma I; Boehm BO; Pociot F; Concannon P; Morahan G
J Immunol; 2016 Apr; 196(7):3043-53. PubMed ID: 26912320
[TBL] [Abstract][Full Text] [Related]
15. Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders.
Jeng MY; Mumbach MR; Granja JM; Satpathy AT; Chang HY; Chang ALS
J Invest Dermatol; 2019 Mar; 139(3):605-614. PubMed ID: 30315781
[TBL] [Abstract][Full Text] [Related]
16. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.
López Rodríguez M; Kaminska D; Lappalainen K; Pihlajamäki J; Kaikkonen MU; Laakso M
Genome Med; 2017 Jul; 9(1):63. PubMed ID: 28683826
[TBL] [Abstract][Full Text] [Related]
18. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
19. Integrative functional analysis of super enhancer SNPs for coronary artery disease.
Gong J; Qiu C; Huang D; Zhang Y; Yu S; Zeng C
J Hum Genet; 2018 May; 63(5):627-638. PubMed ID: 29491472
[TBL] [Abstract][Full Text] [Related]
20. Multiple single nucleotide polymorphisms in the first intron of the IL2RA gene affect transcription factor binding and enhancer activity.
Schwartz AM; Demin DE; Vorontsov IE; Kasyanov AS; Putlyaeva LV; Tatosyan KA; Kulakovskiy IV; Kuprash DV
Gene; 2017 Feb; 602():50-56. PubMed ID: 27876533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
